Sort
78,016 grants matching “breast cancer”
Nano-scale proteomic analysis: development, implementation, and applications
$681,836Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Impact of Cellular and Extracellular Host Components on Tumor Progression
$681,657Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2013 · CA
Chemistry and Biology of Platinum Anticancer Drugs
$681,616Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2011 · CA
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
$681,609Dawn Hershman · Columbia University Health Sciences · P50 · FY2023 · MD
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
$681,600David J. Margolis · University Of Pennsylvania · U01 · FY2025 · AR
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers
$681,511Timothy R Rebbeck · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Determinants of Breast Cancer Survival
$681,469University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA
Appraisal and Diagnostic Delay in Colon Cancer
$681,467Laura A Siminoff · Virginia Commonwealth University · R01 · FY2009 · CA
The Bumps ad device for rapid non invasive quantification of touch sensation
$681,393William R Kennedy · Neuro Devices, Inc. · R42 · FY2014 · TR
Nuclear Dysfunction in Cancer: The Role of Mechanical Stresses Transmitted by the LINC Complex
$681,368Tanmay P. Lele · University Of Florida · U01 · FY2020 · CA
Steroid Hormone Genes and Ovarian Cancer Risk
$681,317Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Effectiveness and implementation of a health system intervention to improve quality of cancer care for rural, underserved patients
$681,297Mary E. Charlton · University Of Iowa · R01 · FY2024 · CA
Assessment of sensory gating, attention, and executive control in breast cancer
$681,234Tim Alan Ahles · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Intra-operative confocal imaging to guide Mohs surgery
$681,221Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2010 · EB
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$681,204Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
$681,132Kevin Charles Oeffinger · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Radiomic and genomic predictors of breast cancer risk
$681,064Weiva Sieh · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Radiation-induced translational control of gene expression
$681,047Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
IGF::OT::IGF Targeting the mTOR Pathway for the Prevention of Breast Cancer
$681,028Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2017 · CA
SOFTWARE ARCHITECTURE FOR GUIDELINE DIRECTED THERAPY
$680,964Stanford University · R01 · FY2002 · LM
Genetic Susceptibility And The Environment In Cancer Risk
$680,942Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Chemistry and Biology of Platinum Anticancer Drugs
$680,883Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2012 · CA
Genetics and Epigenetics of Cancer
$680,856Maxwell P Lee · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care
$680,845Ann B. Nattinger · Medical College Of Wisconsin · R01 · FY2015 · CA
Identification of human tumor-associated antigens
$680,834Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA